Triple

Target class: pharmacovigilance authority
Context triple: [NoMA, instanceOf, pharmacovigilance authority]

• A. pharmacovigilance body chosen
  A pharmacovigilance body is an organization responsible for monitoring, assessing, and preventing adverse effects or other drug-related problems to ensure the ongoing safety and effective use of medicines.
• B. organ of the European Medicines Agency
  An organ of the European Medicines Agency is a formal decision-making or advisory body within the EMA’s governance structure, such as its Management Board, Executive Director, or scientific committees, responsible for specific regulatory, administrative, or scientific functions.
• C. center of the U.S. Food and Drug Administration
  The center of the U.S. Food and Drug Administration is the primary organizational unit within the FDA responsible for regulating and overseeing a specific category of products, such as drugs, biologics, or medical devices, to ensure their safety and effectiveness.
• D. U.S. Food and Drug Administration center
  A U.S. Food and Drug Administration center is a specialized organizational unit within the FDA responsible for regulating and overseeing specific categories of products, such as drugs, biologics, medical devices, or food, to ensure their safety, effectiveness, and proper labeling.
• E. organ of the International Council for Harmonisation
  An organ of the International Council for Harmonisation is a formal body or component within the ICH structure that is responsible for developing, coordinating, or overseeing international guidelines and activities related to the harmonisation of pharmaceutical regulation.
• F. None of above.